Who We Are
We are a global coalition of investigators united in a common mission to develop new treatments for X-Linked Dystonia-Parkinsonism (XDP), a rare neurodegenerative disease affecting individuals from the island of Panay in the Philippines. Our structure is organized around core faculty labs at Massachusetts General Hospital (MGH) that are connected to a network of basic scientists, clinical investigators, and patient advocates at institutions throughout North America, Europe, and Asia. Working together as a consortium, our scientists have identified the pathogenic gene variant associated with XDP and are developing new stem cell and animal models for probing disease mechanisms and testing candidate therapeutics. Now with an expanding consortium of academic investigators and industry partners, we are moving faster than ever before to translate our basic discoveries into potential new therapies.
Our Culture
At the Collaborative Center for X-Linked Dystonia-Parkinsonism, we believe in the power of Team Science.
Our core faculty labs are a rich, collaborative environment led by investigators with affiliations spanning MGH, Harvard Medical School, the Harvard Stem Cell Institute, and the Broad. Our staff meet in multi-disciplinary project teams that connect personnel based at MGH with CCXDP scientists at other institutions – all guided by the philosophy that we can accomplish more by working together than we can individually. These research initiatives are driven by scientists at all career levels, from faculty members and staff scientists to postdoctoral fellows, students, and technicians. And because our mission is to translate basic discoveries into clinical interventions, our basic scientists work side by side with the clinical investigators characterizing patterns of disease in patients.
Current Openings
We are not currently recruiting for open positions, but feel free to reach out to XDPCenter@MGB.org for any questions on careers.
